berberine has been researched along with Liver Dysfunction in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) is a known alkaloid that has verified its protective effects against ischemia/reperfusion (I/RN) lesion in multiple organs but its poor oral bioavailability limited its use." | 1.72 | Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy. ( Allam, MM; El-Haddad, AE; El-Mancy, SS; Elnagar, MR; Elnahas, OS; Fayez, SM; Gendy, AM; Khodir, AE; Mousa, MR, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gendy, AM | 1 |
| Elnagar, MR | 1 |
| Allam, MM | 1 |
| Mousa, MR | 1 |
| Khodir, AE | 1 |
| El-Haddad, AE | 1 |
| Elnahas, OS | 1 |
| Fayez, SM | 1 |
| El-Mancy, SS | 1 |
| Zhou, M | 1 |
| Deng, Y | 1 |
| Liu, M | 1 |
| Liao, L | 1 |
| Dai, X | 1 |
| Guo, C | 1 |
| Zhao, X | 1 |
| He, L | 1 |
| Peng, C | 1 |
| Li, Y | 1 |
| Zhang, H | 1 |
| Wei, J | 1 |
| Xue, R | 1 |
| Wu, JD | 1 |
| Zhao, W | 1 |
| Wang, ZZ | 1 |
| Wang, SK | 1 |
| Zhou, ZX | 1 |
| Song, DQ | 1 |
| Wang, YM | 1 |
| Pan, HN | 1 |
| Kong, WJ | 1 |
| Jiang, JD | 1 |
1 review available for berberine and Liver Dysfunction
| Article | Year |
|---|---|
The pharmacological activity of berberine, a review for liver protection.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Berberine; Drug Compounding; Humans; Liver | 2021 |
1 trial available for berberine and Liver Dysfunction
| Article | Year |
|---|---|
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Topics: Aged; Berberine; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Female; Gene Expression; Human | 2010 |
1 other study available for berberine and Liver Dysfunction
| Article | Year |
|---|---|
Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Autophagy; Berberine; Drug Carriers; HMGB1 Protein; Li | 2022 |